NCT03004755 The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study Status RECRUITING Phase N/A
NCT02933320 BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia Status COMPLETED Phase PHASE1/PHASE2
NCT02866370 Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium Status UNKNOWN Phase PHASE2
NCT02758587 Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) Status UNKNOWN Phase PHASE1/PHASE2
NCT02752204 An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma Status COMPLETED Phase PHASE2
NCT02741856 Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation Status UNKNOWN Phase PHASE2/PHASE3
NCT02724163 International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia Status RECRUITING Phase PHASE3
NCT02688257 Assessing Treatment Response in Breast Cancer With Functional Imaging Status COMPLETED Phase N/A
NCT02664935 National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02583542 A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers Status UNKNOWN Phase PHASE1/PHASE2
NCT02544308 Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02530411 Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer Status UNKNOWN Phase PHASE2
NCT02457156 Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy Status COMPLETED Phase PHASE3
NCT02423603 PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE2